CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ)

Francini, Edoardo; Fang-Shu, Ou; Lazzi, Stefano; Petrioli, Roberto; Multari, Andrea Giovanni; Pesola, Guido; Messuti, Luciana; Colombo, Elena; Livellara, Virginia; Bazzurri, Serena; Cherri, Sara; Salvatora, Miano; Wolfe, Eric; Alberts, Steven R; Hubbard, Joleen Marie; Yoon, Harry H.; Francini, Guido

doi:10.1200/JCO.2020.38.4_suppl.167

https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.4_suppl.167

CD3+ tumor-infiltrating lymphocytes (TILs) as prognostic in patients (pts) with stage II colon cancer (CC) not treated with adjuvant chemotherapy (ADJ) / Francini, E., Ou, F., Lazzi, S., Petrioli, R., Multari, A.G., Pesola, G., Messuti, L., Colombo, E., Livellara, V., Bazzurri, S., Cherri, S., Salvatora, M., Wolfe, E., Alberts, S.R., Hubbard, J.M., Yoon, H.H., Francini, G.. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - ELETTRONICO. - 38:(2020), pp. 167-167. [10.1200/JCO.2020.38.4_suppl.167]